This study proved that MOBT alleviated pulmonary fibrosis through downregulating the lncITPF–hnRNP-l-complex-targeted MEF2c signaling pathway in vitro and in vivo. The gene discussed is HNRNPL; the disease is pulmonary fibrosis.